Advertisement


Covaxin
India  /  Published 03.01.21

Covaxin jumps direct evidence

India’s drug regulatory expert panel on Saturday recommended conditional and restricted emergency use of a home-grown vaccine against the coronavirus disease without direct evidence for its prot...
By G.S. Mudur in New Delhi

India  /  Published 02.01.21

Homegrown Covaxin gets nod

Covaxin, the anti-coronavirus vaccine developed indigenously by India’s Hyderabad-based Bharat Biotech, has received restricted emergency use permission, with certain conditions, from an expert ...
By Our Bureau and Agencies in New Delhi

India  /  Published 01.01.21

Oxford vaccine emergency use

An expert panel on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford Covid-19 vaccine Covishield in I...
By Payal Banerjee in New Delhi

India  /  Published 29.12.20

Covaxin can take on mutated coronavirus

Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krish...
By Our Bureau and Agencies in Hyderabad

India  /  Published 24.12.20

Covaxin trials offer long-term immunity hope

India’s homegrown candidate vaccine against the novel coronavirus disease developed by the Hyderabad-based Bharat Biotech has generated a dual immune response that has raised hopes of immunity l...
By G.S. Mudur in New Delhi

Advertisement


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.